Eswatini vs Guinea-Bissau: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Eswatini
90.0%
in 2025
Guinea-Bissau
90.0%
in 2025
Eswatini rank
68th
Guinea-Bissau rank
68th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Eswatini
- Guinea-Bissau
How they compare
Eswatini currently reports 90.0% against 90.0% in Guinea-Bissau, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Guinea-Bissau ahead.
Eswatini ranks 68th and Guinea-Bissau ranks 68th of 192 countries.
Across the 3 decades both report, Eswatini averaged higher in 1 and Guinea-Bissau in 1.
Head to head by decade
| Decade | Eswatini | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 50.9% | 34.1% | 16.8% | Eswatini |
| 2020s | 79.3% | 85.5% | 6.2% | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Eswatini or Guinea-Bissau?
- Eswatini, at 90.0% against 90.0% in Guinea-Bissau as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Eswatini and Guinea-Bissau?
- 0.0%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Guinea-Bissau?
- 18 years are reported by both, from 2008 to 2025.
- How do Eswatini and Guinea-Bissau rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Eswatini ranks 68th and Guinea-Bissau ranks 68th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.